C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 114 filers reported holding C4 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,000 | +1000.0% | 5,804 | +936.4% | 0.00% | – |
| Q2 2023 | $1,000 | -88.9% | 560 | -80.9% | 0.00% | – |
| Q1 2023 | $9,000 | -81.6% | 2,933 | -64.6% | 0.00% | – |
| Q4 2022 | $49,000 | +444.4% | 8,286 | +683.9% | 0.00% | – |
| Q3 2022 | $9,000 | +50.0% | 1,057 | +35.5% | 0.00% | – |
| Q2 2022 | $6,000 | -90.0% | 780 | -68.2% | 0.00% | – |
| Q1 2022 | $60,000 | -83.7% | 2,456 | -78.6% | 0.00% | – |
| Q4 2021 | $369,000 | +8.2% | 11,475 | +50.5% | 0.00% | – |
| Q3 2021 | $341,000 | +74.0% | 7,625 | +47.3% | 0.00% | – |
| Q2 2021 | $196,000 | +493.9% | 5,177 | +472.0% | 0.00% | – |
| Q1 2021 | $33,000 | -2.9% | 905 | -11.5% | 0.00% | – |
| Q4 2020 | $34,000 | – | 1,023 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |